Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 18, 2018
- Accepted in final form January 10, 2019
- First Published April 12, 2019.
Article Versions
- Previous version (April 12, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Marienke A.A.M. de Bruijn, MD,
- Agnes van Sonderen, MD, PhD,
- Marleen H. van Coevorden-Hameete, MD, PhD,
- Anna E.M. Bastiaansen, MD,
- Marco W.J. Schreurs, PhD,
- Rob P.W. Rouhl, MD, PhD,
- Cees A. van Donselaar, MD, PhD,
- Marian H.J.M. Majoie, MD, PhD,
- Rinze F. Neuteboom, MD, PhD,
- Peter A.E. Sillevis Smitt, MD, PhD,
- Roland D. Thijs, MD, PhD and
- Maarten J. Titulaer, MD, PhD
- Marienke A.A.M. de Bruijn, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Agnes van Sonderen, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marleen H. van Coevorden-Hameete, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anna E.M. Bastiaansen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marco W.J. Schreurs, PhD,
NONE
NONE
(1) Thermo Scientific, funding for travel to conference (2) Inova, funding for travel to conference
(1) Nederlands tijdschrift voor Allergie & Astma, editorial advisory board member, 2015-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Combined ophthalmic research, Rotterdam (2) Stichting de Merel, Den Haag (3) Stichting Blindenbelangen, Rotterdam
NONE
NONE
NONE
NONE
NONE
NONE
- Rob P.W. Rouhl, MD, PhD,
NONE
NONE
1) UCB Pharma, compensation for lectures
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) FHML Scannexus Fund 2) Center for Integrative Neurosciences Fund
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cees A. van Donselaar, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marian H.J.M. Majoie, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Erasmus + Projectnumber: 20 18- 1-NL0 1-KA203-O39O7O Projecttitle: European Partnership on Competencies for High Value COst COnscious CARE.
NONE
NONE
NONE
NONE
NONE
NONE
- Rinze F. Neuteboom, MD, PhD,
Data safety monitory board: EXCEL study (neurofibromatosis) (non profit entity()
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter A.E. Sillevis Smitt, MD, PhD,
NONE
NONE
NONE
NONE
P. Sillevis Smitt holds a patent for the detection of anti- DNER.
NONE
NONE
NONE
NONE
NONE
NONE
Peter Sillevis Smitt received a research grant from Euroimmun.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Roland D. Thijs, MD, PhD and
NONE
NONE
Medtronic: speakers and travel honorarium UCB: speakers honorarium GSK: speakers honorarium
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medtronic Inc.
NONE
NONE
Dutch Epilepsy Foundation Nuts Ohra Foundation AC Thomson Foundation The Netherlands Organisation for Health Research and Development (ZonMW)
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Titulaer, MD, PhD
NONE
NONE
NONE
(1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014
(1) filed a patent for
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medimmune LLC, research funds for serving on the scientific advisory board; (2) Guidepoint Global LLC, research funds for consultancy; (3) Novartis, research funds for teaching; (4) unrestricted research grant from Euroimmun AG.
(1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive and Memorabel initiative)
(1) Previously supported by an ErasmusMC fellowship
(1) supported by the Dutch Epilepsy Foundations, projectnumber 14-19.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (M.A.A.M.d.B., A.v.S., M.H.v.C.-H., A.E.M.B., P.A.E.S.S., M.J.T.), Immunology (M.W.J.S.), and Pediatric Neurology (R.F.N.), Erasmus MC University Medical Center, Rotterdam; Haga Hospital (A.v.S.), the Hague; Department of Neurology (R.P.W.R., M.H.J.M.M.), Maastricht UMC+, Maastricht; Department of Neurology (C.A.v.D.), Maasstad Hospital, Rotterdam; Department of Neurology (M.J.M.M.), Academic Center of Epileptology Kempenhaeghe; Sophia Children's Hospital (R.F.N.), Rotterdam; Department of Neurology (R.D.T.), Stichting Epilepsie Instellingen Nedederland (SEIN), Heemstede; and Department of Neurology (R.D.T.), Leiden University Medical Center (LUMC), the Netherlands.
- Correspondence
Dr. Titulaer m.titulaer{at}erasmusmc.nl
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.